miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
Tianzhen Wang(Nanjing University of Chinese Medicine), Xiaobo Li(Shanxi Medical University), Xiaoming Jin(Beijing Union University), Shucai Yang(Harbin Medical University), Dapeng Hao(The University of Texas MD Anderson Cancer Center), Yuanyuan Zhu(First Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Zhiwei Li(Changsha University of Science and Technology), Yafei Li(Army Medical University), Guangyu Wang(Tongji University), Xuefei Wang(Union Hospital), Chao Yang(Harbin Medical University), Jianhui Ma(Harbin Medical University), Yukuan Feng(Tianjin Medical University Cancer Institute and Hospital), Di Wu(Army Medical University), Yan He(Nanchang University), Lei Zhang(Harbin Medical University), Jing Tang(Harbin Medical University), Xiang An(Harbin Medical University), Weiwei Yang(Ningxia Medical University), Hongxue Meng(Harbin Medical University), Mingjiao Weng(Harbin Medical University), Tongsen Zheng(Harbin Medical University)
Cited by 43
Related Papers
Targeting PI3K/Akt signal transduction for cancer therapy
|Signal Transduction and Targeted Therapy|2021|1.7k
Inhibition of JNK activation through NF-κB target genes
|Nature|2001|719
<p>Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles</p>
|International Journal of Nanomedicine|2020|347
An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
|Molecular Therapy — Nucleic Acids|2018|211
Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
|Cancer Research|2019|207